A generalizable pre-clinical research approach for orphan disease therapy

التفاصيل البيبلوغرافية
العنوان: A generalizable pre-clinical research approach for orphan disease therapy
المؤلفون: Beaulieu, C. L., Samuels, M. E., Ekins, S., McMaster, C. R., Edwards, A. M., Krainer, A. R., Hicks, G. G., Frey, B. J., Boycott, K. M., Mackenzie, A. E.
سنة النشر: 2012
المجموعة: Cold Spring Harbor Laboratory: CSHL Institutional Repository
مصطلحات موضوعية: diseases & disorders, Investigative techniques and equipment
الوصف: With the advent of next-generation DNA sequencing, the pace of inherited orphan disease gene identification has increased dramatically, a situation that will continue for at least the next several years. At present, the numbers of such identified disease genes significantly outstrips the number of laboratories available to investigate a given disorder, an asymmetry that will only increase over time. The hope for any genetic disorder is, where possible and in addition to accurate diagnostic test formulation, the development of therapeutic approaches. To this end, we propose here the development of a strategic toolbox and preclinical research pathway for inherited orphan disease. Taking much of what has been learned from rare genetic disease research over the past two decades, we propose generalizable methods utilizing transcriptomic, system-wide chemical biology datasets combined with chemical informatics and, where possible, repurposing of FDA approved drugs for pre-clinical orphan disease therapies. It is hoped that this approach may be of utility for the broader orphan disease research community and provide funding organizations and patient advocacy groups with suggestions for the optimal path forward. In addition to enabling academic pre-clinical research, strategies such as this may also aid in seeding startup companies, as well as further engaging the pharmaceutical industry in the treatment of rare genetic disease.
نوع الوثيقة: report
وصف الملف: application/pdf
اللغة: English
Relation: http://repository.cshl.edu/id/eprint/26897/1/Krainer%20Orphanet%20Journal%20of%20Rare%20Diseases%202012.pdf; Beaulieu, C. L., Samuels, M. E., Ekins, S., McMaster, C. R., Edwards, A. M., Krainer, A. R., Hicks, G. G., Frey, B. J., Boycott, K. M., Mackenzie, A. E. (June 2012) A generalizable pre-clinical research approach for orphan disease therapy. Orphanet J Rare Dis, 7. pp. 1750-1172. ISSN 1750-1172 (Electronic)1750-1172 (Linking)
DOI: 10.1186/1750-1172-7-39
الاتاحة: http://repository.cshl.edu/id/eprint/26897/
http://repository.cshl.edu/id/eprint/26897/1/Krainer%20Orphanet%20Journal%20of%20Rare%20Diseases%202012.pdf
http://www.ncbi.nlm.nih.gov/pubmed/22704758
https://doi.org/10.1186/1750-1172-7-39
رقم الانضمام: edsbas.5776DFA1
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.5776DFA1
759
3
Report
report
758.984313964844
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.5776DFA1&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => http://repository.cshl.edu/id/eprint/26897/# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => A generalizable pre-clinical research approach for orphan disease therapy )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Beaulieu%2C+C%2E+L%2E%22">Beaulieu, C. L.</searchLink><br /><searchLink fieldCode="AR" term="%22Samuels%2C+M%2E+E%2E%22">Samuels, M. E.</searchLink><br /><searchLink fieldCode="AR" term="%22Ekins%2C+S%2E%22">Ekins, S.</searchLink><br /><searchLink fieldCode="AR" term="%22McMaster%2C+C%2E+R%2E%22">McMaster, C. R.</searchLink><br /><searchLink fieldCode="AR" term="%22Edwards%2C+A%2E+M%2E%22">Edwards, A. M.</searchLink><br /><searchLink fieldCode="AR" term="%22Krainer%2C+A%2E+R%2E%22">Krainer, A. R.</searchLink><br /><searchLink fieldCode="AR" term="%22Hicks%2C+G%2E+G%2E%22">Hicks, G. G.</searchLink><br /><searchLink fieldCode="AR" term="%22Frey%2C+B%2E+J%2E%22">Frey, B. J.</searchLink><br /><searchLink fieldCode="AR" term="%22Boycott%2C+K%2E+M%2E%22">Boycott, K. M.</searchLink><br /><searchLink fieldCode="AR" term="%22Mackenzie%2C+A%2E+E%2E%22">Mackenzie, A. E.</searchLink> )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2012 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Cold Spring Harbor Laboratory: CSHL Institutional Repository )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22diseases+%26+disorders%22">diseases & disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Investigative+techniques+and+equipment%22">Investigative techniques and equipment</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => With the advent of next-generation DNA sequencing, the pace of inherited orphan disease gene identification has increased dramatically, a situation that will continue for at least the next several years. At present, the numbers of such identified disease genes significantly outstrips the number of laboratories available to investigate a given disorder, an asymmetry that will only increase over time. The hope for any genetic disorder is, where possible and in addition to accurate diagnostic test formulation, the development of therapeutic approaches. To this end, we propose here the development of a strategic toolbox and preclinical research pathway for inherited orphan disease. Taking much of what has been learned from rare genetic disease research over the past two decades, we propose generalizable methods utilizing transcriptomic, system-wide chemical biology datasets combined with chemical informatics and, where possible, repurposing of FDA approved drugs for pre-clinical orphan disease therapies. It is hoped that this approach may be of utility for the broader orphan disease research community and provide funding organizations and patient advocacy groups with suggestions for the optimal path forward. In addition to enabling academic pre-clinical research, strategies such as this may also aid in seeding startup companies, as well as further engaging the pharmaceutical industry in the treatment of rare genetic disease. )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => report )
Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => http://repository.cshl.edu/id/eprint/26897/1/Krainer%20Orphanet%20Journal%20of%20Rare%20Diseases%202012.pdf; Beaulieu, C. L., Samuels, M. E., Ekins, S., McMaster, C. R., Edwards, A. M., Krainer, A. R., Hicks, G. G., Frey, B. J., Boycott, K. M., Mackenzie, A. E. (June 2012) A generalizable pre-clinical research approach for orphan disease therapy. Orphanet J Rare Dis, 7. pp. 1750-1172. ISSN 1750-1172 (Electronic)1750-1172 (Linking) )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1186/1750-1172-7-39 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => http://repository.cshl.edu/id/eprint/26897/<br />http://repository.cshl.edu/id/eprint/26897/1/Krainer%20Orphanet%20Journal%20of%20Rare%20Diseases%202012.pdf<br />http://www.ncbi.nlm.nih.gov/pubmed/22704758<br />https://doi.org/10.1186/1750-1172-7-39 )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.5776DFA1 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1186/1750-1172-7-39 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => diseases & disorders [Type] => general ) [1] => Array ( [SubjectFull] => Investigative techniques and equipment [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => A generalizable pre-clinical research approach for orphan disease therapy [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Beaulieu, C. L. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Samuels, M. E. ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ekins, S. ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => McMaster, C. R. ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Edwards, A. M. ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Krainer, A. R. ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Hicks, G. G. ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Frey, B. J. ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Boycott, K. M. ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Mackenzie, A. E. ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2012 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) ) ) ) ) ) )
IllustrationInfo